|
Volumn 77, Issue 1, 2005, Pages 107-109
|
Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care [2]
|
Author keywords
Antipsychotics; Drug promotion; Primary care
|
Indexed keywords
AMISULPRIDE;
NEUROLEPTIC AGENT;
OLANZAPINE;
RISPERIDONE;
ADULT;
CONSULTATION;
DRUG INDUSTRY;
DRUG MARKETING;
FEMALE;
GENERAL PRACTITIONER;
HEALTH PROMOTION;
HEALTH SURVEY;
HUMAN;
LETTER;
MALE;
PHYSICIAN ATTITUDE;
PRESCRIPTION;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
QUESTIONNAIRE;
SCHIZOPHRENIA;
ADULT;
ANTIPSYCHOTIC AGENTS;
DRUG INDUSTRY;
DRUG INFORMATION SERVICES;
DRUG UTILIZATION;
FEMALE;
HUMANS;
LOGISTIC MODELS;
MALE;
MENTAL DISORDERS;
MIDDLE AGED;
PRESCRIPTIONS, DRUG;
PRIMARY HEALTH CARE;
QUESTIONNAIRES;
|
EID: 21844435248
PISSN: 09209964
EISSN: None
Source Type: Journal
DOI: 10.1016/j.schres.2005.02.001 Document Type: Letter |
Times cited : (8)
|
References (8)
|